Pregled bibliografske jedinice broj: 1249529
Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors
Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors // International journal of cardiology, 371 (2022), 391-396 doi:10.1016/j.ijcard.2022.09.037 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1249529 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Management and outcomes of patients admitted with
type 2 myocardial infarction with and without
standard modifiable risk factors
Autori
Sokhal, Balamrit Singh ; Matetić, Andrija ; Paul, Timir K. ; Velagapudi, Poonam ; Lambrinou, Ekaterini ; Figtree, Gemma A. ; Rashid, Muhammad ; Moledina, Saadiq ; Vassiliou, Vassilios S. ; Mallen, Christian ; Mamas, Mamas A.
Izvornik
International journal of cardiology (0167-5273) 371
(2022);
391-396
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
acute myocardial infarction ; Risk factors ; Outcomes ; National Inpatient Sample
Sažetak
Background: Whilst it is known patients without standard modifiable cardiovascular risk factors (SMuRF ; hy-pertension, diabetes, hypercholesterolaemia, smoking) have worse outcomes in Type 1 acute myocardial infarction (AMI), the relationship between type 2 AMI (T2AMI) and outcomes in patients with and without SMuRF is unknown. This study aimed to determine the prevalence, characteristics and clinical outcomes of patients hospitalised with T2AMI based on the presence of SMuRF. Methods: Using the National Inpatient Sample, all hospitalizations with a primary discharge diagnosis of T2AMI were stratified according to SMuRF status (SMuRF and SMURF-less). Primary outcome was all-cause mortality while secondary outcomes were major adverse cardiovascular and cerebrovascular events (MACCE), major bleeding and ischemic stroke. Multivariable logistic regression was used to determine adjusted odds ratios (aOR) with 95% confidence intervals (95% CI). Results: Among 17, 595 included hospitalizations, 1345 (7.6%) were SMuRF-less and 16, 250 (92.4%) were SMuRF. On adjusted analysis, SMuRF-less patients had increased odds of all-cause mortality (aOR 2.43, 95% CI 1.83 to 3.23), MACCE (aOR 2.32, 95% CI 1.79 to 2.90) and ischaemic stroke (aOR 2.57, 95% CI 1.56 to 4.24) compared to their SMuRF counterparts. Secondary diagnoses among both cohorts were similar, with respiratory disorders most prevalent followed by cardiovascular and renal disorders. Conclusions: T2AMI in the absence of SMuRF was associated with worse in-hospital outcomes compared to SMuRF-less patients. There was no SMuRF-based difference in the secondary diagnoses with the most common being respiratory, cardiovascular, and renal disorders. Further studies are warranted to improve overall care and outcomes of SMuRF-less patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE